Literature DB >> 32679625

Relationship of lymph node status with survival and recurrence among women with endometrial cancer.

Osman Cagin Buldukoglu1, Alev Turker2, Alp Usubutun3, Mehmet Coskun Salman4.   

Abstract

OBJECTIVE: To explore the relationship of lymph node ratio (LNR) and other lymph node parameters with disease-free (DFS) and overall (OS) survival among women with endometrial cancer.
METHODS: Retrospective analysis of data of women diagnosed with endometrial cancer at Hacettepe University Hospitals, Ankara, Turkey, between 2003 and 2013. Women who had their surgical procedure, pathology review, and follow-up at Hacettepe University Hospitals were included in the study. Receiver operator characteristic (ROC) curve analysis was used to determine the threshold LNR associated with survival.
RESULTS: Overall, 376 women were included in the study. A higher number of excised metastatic lymph nodes was associated with decreased survival. ROC curve analysis determined a threshold LNR of 0.03. Women with LNR higher than 0.03 had decreased DFS (P<0.001) and OS (P<0.001) relative to those with LNR of 0.03 or lower. LNR of 0.1 was found to be a significant cutoff value for DFS (P=0.023) and OS (P=0.036) among women with at least one metastatic lymph node.
CONCLUSION: LNR may be used as a prognostic tool in endometrial cancer. Future studies will help to define a precise threshold of LNR in order to implement this prognostic factor in daily practice.
© 2020 International Federation of Gynecology and Obstetrics.

Entities:  

Keywords:  Endometrial carcinoma; Lymph node; Lymph node count; Lymph node ratio; Prognosis; Recurrence; Survival

Mesh:

Year:  2020        PMID: 32679625     DOI: 10.1002/ijgo.13309

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  5 in total

1.  Serum miRNA-204-5p as a potential non-invasive biomarker for the diagnosis of endometrial cancer with sentinel lymph node mapping.

Authors:  Cailiang Wu; Xuexin Zhou; Jiayong Li; Ruiying Xiao; Haomin Xin; Lei Dai; Yaping Zhu; Wei Bao
Journal:  Oncol Lett       Date:  2022-06-07       Impact factor: 3.111

2.  Comparison of Different Lymph Node Staging Schemes for Predicting Survival Outcomes in Node-Positive Endometrioid Endometrial Cancer Patients.

Authors:  Xi-Lin Yang; Nan Huang; Ming-Ming Wang; Hua Lai; Da-Jun Wu
Journal:  Front Med (Lausanne)       Date:  2021-07-09

3.  SuMO-Fil: Supervised multi-omic filtering prior to performing network analysis.

Authors:  Lorin M Towle-Miller; Jeffrey C Miecznikowski; Fan Zhang; David L Tritchler
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

4.  Sera Protein Signatures of Endometrial Cancer Lymph Node Metastases.

Authors:  Doris Mangiaracina Benbrook; James Randolph Sanders Hocker; Katherine Marie Moxley; Jay S Hanas
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

5.  Is routine frozen section analysis necessary in patients with non-endometrioid cancer or grade 3 endometrioid cancer?

Authors:  Qingyong Guo; Huan Yi; Xiaodan Chen; Jianrong Song; Lingsi Chen; Xiangqin Zheng
Journal:  Int J Gynaecol Obstet       Date:  2021-05-12       Impact factor: 4.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.